EUVIMEDEUVIMED entdecken
Crossref

Radiological Complete Response as a Prognostic Marker in HR-positive Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: Implications for Treatment De-escalation

Wataru Goto, Shinichiro Kashiwagi, Mariko Nishikawa, Chika Watanabe, Koji Takada, Yukie Tauchi, Kana Ogisawa, Masatsune Shibutani, Haruhito Kinoshita, Tamami Morisaki

Anticancer Research · 2026

DOI: 10.21873/anticanres.17946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Wataru Goto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgical Oncology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Protein Kinase Inhibitors.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6Protein Kinase InhibitorsHumansFemaleMiddle AgedAgedRetrospective StudiesPrognosisAdultReceptors, EstrogenErb-b2 Receptor Tyrosine KinasesReceptors, ProgesteroneAged, 80 and overAminopyridinesNeoplasm MetastasisBiomarkers, TumorTreatment OutcomeBenzimidazoles

Stichwörter der Autor:innen

Breast cancerCDK4/6 inhibitorendocrine therapyradiological complete responsetherapy de-escalation

Substanzen

Cyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6Protein Kinase InhibitorsReceptors, EstrogenErb-b2 Receptor Tyrosine KinasesReceptors, ProgesteroneAminopyridinesBiomarkers, TumorBenzimidazolesCDK6 protein, human

Autor:innen und Institutionen

  • Department of Breast Surgical Oncology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Department of Breast Surgical Oncology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan; spqv9ke9@view.ocn.ne.jp.
  • Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

Zitieren

APA

Goto, W., Kashiwagi, S., Nishikawa, M., Watanabe, C., Takada, K., Tauchi, Y., Ogisawa, K., Shibutani, M., Kinoshita, H., & Morisaki, T. (2026). Radiological Complete Response as a Prognostic Marker in HR-positive Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: Implications for Treatment De-escalation. Anticancer Research. https://doi.org/10.21873/anticanres.17946

Vancouver

Goto W, Kashiwagi S, Nishikawa M, Watanabe C, Takada K, Tauchi Y, et al. Radiological Complete Response as a Prognostic Marker in HR-positive Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: Implications for Treatment De-escalation. Anticancer Research. 2026. doi:10.21873/anticanres.17946

BibTeX
@article{Goto2026,
  author = {Goto, Wataru and Kashiwagi, Shinichiro and Nishikawa, Mariko and Watanabe, Chika and Takada, Koji and Tauchi, Yukie and Ogisawa, Kana and Shibutani, Masatsune and Kinoshita, Haruhito and Morisaki, Tamami},
  title = {Radiological Complete Response as a Prognostic Marker in HR-positive Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: Implications for Treatment De-escalation},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.17946}
}
Kostenlos starten →